Compounded ophthalmic syringes recalled over an incorrect product formulation
Fagron Compounding Services is recalling 2,980 syringes of a compounded topical ophthalmic solution over an incorrect product formulation.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 because the record cites an incorrect formulation without describing the difference, a consequence or any reported harm.
Plain-English summary
Tropicamide 1% / Cyclopentolate 1% / Phenylephrine 2.5% / Ketorolac 0.5% Topical Ophthalmic Solution, in 0.5mL single-use syringes for topical ophthalmic use only and not for IV use, from Fagron Sterile Services of Wichita, Kansas, under NDC 71266-8240, is being recalled.
The reason given in the enforcement record is incorrect product formulation.
The recall covers 2,980 syringes from lot C274-000047958, expiry December 19, 2025. Distribution was nationwide in the United States. The FDA has classified the action as Class II.
The record does not describe how the formulation differed or state a consequence, and reports no injuries. Facilities should quarantine the affected lot and follow Fagron's instructions.
The recalled product
- Product
- Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67226. NDC: 71266-8240-01
- Manufacturer
- Fagron Compounding Services
- Category
- Drug — Compounded ophthalmic
- Hazard
- incorrect-formulation
- compounding
- ophthalmic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot#: C274-000047958
- Exp. December 19
- 2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22